AstraZeneca
The role leads a new AI organization across Cell Therapy Discovery and Targeted Immune Engagers, defining strategy, building a centralized team of AI experts, and delivering high‑impact AI solutions such as predictive CAR‑T models, in‑silico binder design, and CRISPR safety workflows. Reporting to the SVP for IO Discovery and Cell Therapy Oncology, the leader will embed AI as a core capability, drive governance, and translate technical insights into business value.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
13% above the average for this role
Sr. Scientist I Cellular/Molecular Biology
AbbVie
T-Cell Engineering Scientist
Mayo Clinic
T-Cell Engineering Scientist
Mayo Clinic
Physician – BMT/Cellular Therapy: Baptist Cancer Center
oraclecloudinfrastructure
Postdoctoral Research Fellow
Eli Lilly and Company
Artificial Intelligence (AI) Solutions Engineer
Lexical